Location History:
- Saitama, JP (2013)
- Tokyo, JP (2017 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Manish Biyani: Innovator in Nucleic Acid Technology
Introduction
Manish Biyani is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of nucleic acid technology, holding a total of 4 patents. His work focuses on innovative methods for synthesizing proteins and peptides, which have important applications in biotechnology and medicine.
Latest Patents
One of his latest patents is a nucleic acid linker designed for producing a complex of mRNA and a protein or peptide encoded by the mRNA. This invention includes a spacer portion at the 5'-terminal, a polynucleotide portion that is hybridizable with a part of the mRNA sequence, and an arm portion with a connection for the protein or peptide at the 3'-terminal. The components form a single strand, with the polynucleotide portion containing a photoreactive base derivative.
Another notable patent involves a protein or peptide printing method, which includes preparing nucleic acids and a cell-free protein synthesis system in an engraved plate with microscopic grooves. The method allows for the synthesis and immobilization of proteins or peptides on a substrate, enhancing the efficiency of protein array or peptide array technologies.
Career Highlights
Manish Biyani has worked with prestigious organizations such as the University of Tokyo and Nikon Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Takanori Ichiki and Hirofumi Shiono. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Manish Biyani is a distinguished inventor whose work in nucleic acid technology has the potential to revolutionize the field of biotechnology. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and applications.